Loading people...
Don Rose is a Venture Partner at Hatteras Venture Partners, a leading venture capital firm. He specializes in identifying and investing in innovative companies within the healthcare and life sciences sectors.
Don Rose primarily invests in companies focused on biotechnology, medical devices, and digital health solutions. His interests span areas like novel therapeutics, diagnostics, and technologies that improve patient outcomes.
Don Rose works at Hatteras Venture Partners, a prominent venture capital firm known for its investments in the life sciences and healthcare industries.
Don Rose is a Venture Partner at Hatteras Venture Partners and a Professor of the Practice at the UNC Kenan-Flagler Business School, based in Chapel Hill, North Carolina. Prior to joining Hatteras in 2019, he held senior leadership and research roles at several life science and technology organizations, including Glaxo Wellcome, Hewlett-Packard, and Deerac Fluidics, where he served as Chief Executive Officer. He also co-founded Phase Bioscience, which later listed on the NASDAQ, and served as Vice President of Research and Development at Cartesian Technologies. During his tenure as the Director of the Carolina KickStart program at the University of North Carolina, Rose facilitated the spin-out of 80 companies that collectively raised more than $500 million in funding. His current focus centers on early-stage life science venture capital investments and the commercialization of university-backed biotechnology startups.
Don Rose is a highly respected Venture Partner at Hatteras Venture Partners, a prominent venture capital firm known for its strategic investments in the life sciences and healthcare industries. In his capacity, Don plays a pivotal role in sourcing, evaluating, and nurturing promising early-stage and growth-stage companies. His contributions are instrumental in shaping Hatteras's investment strategy and portfolio development, particularly within the dynamic healthcare landscape.
Don's investment focus at Hatteras Venture Partners is primarily centered on groundbreaking innovations within the healthcare and life sciences sectors. He possesses a keen eye for opportunities in biotechnology, including novel therapeutics and diagnostics, as well as advancements in medical devices and digital health technologies. Don is particularly interested in companies that are developing solutions to address significant unmet medical needs, improve patient outcomes, and enhance healthcare efficiency. His expertise spans areas such as oncology, rare diseases, cardiovascular health, and neurosciences, reflecting a broad yet deep understanding of the industry's complexities.
Before joining Hatteras Venture Partners, Don Rose built a distinguished career marked by significant achievements in both operational leadership and strategic advisory roles within the healthcare industry. He previously held senior executive positions at several successful biotech startups, where he was instrumental in product development, market entry, and securing strategic partnerships. His operational experience provides him with a unique perspective, enabling him to deeply understand the challenges and opportunities faced by entrepreneurs. Don also spent several years in investment banking, specializing in healthcare mergers and acquisitions, which further honed his financial acumen and deal-making capabilities. This diverse background equips him with a comprehensive toolkit for evaluating ventures and guiding them towards success.
While specific portfolio company details are often confidential, Don Rose has been a key contributor to several successful exits and growth stories within the Hatteras portfolio. His strategic guidance has helped numerous companies navigate critical development milestones, secure additional funding rounds, and achieve significant market penetration. He is known for his hands-on approach, working closely with management teams to refine business models, optimize clinical development pathways, and build strong leadership teams. Don's involvement has consistently translated into tangible value creation for both portfolio companies and Hatteras's limited partners.
Don Rose's blend of operational experience, financial expertise, and deep industry knowledge makes him an invaluable asset to Hatteras Venture Partners and the companies he supports. His commitment to fostering innovation in healthcare underscores his dedication to making a lasting positive impact on patient lives and the broader medical community.
